The accuracy and efficacy of real-time continuous glucose monitoring sensor in patients with type 1 diabetes

Diabetes Technology and Therapeutics

Volumn 10, Issue 5, 2008, Pages 385-390

  Mastrototaro, John ^a   Shin, John ^a   Marcus, Alan ^a   Sulur, Giri ^a  

^a MEDTRONIC INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ADOLESCENT; ADULT; ANALYTICAL ERROR; ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INTERNET; MAJOR CLINICAL STUDY; MALE; MICROCOMPUTER; MULTICENTER STUDY; OPEN STUDY; PATIENT SAFETY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SELF MONITORING; SENSOR; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CHILD; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; INSULIN INFUSION SYSTEMS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MONITORING, AMBULATORY; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES;

EID: 50049108982     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2007.0291     Document Type: Article

References (23)

1. Self-monitoring of blood glucose. American Diabetes Association. Diabetes Care 1985;8:515.
2. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993;329:977-986.
3. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:837-853.
4. Genuth S, Eastman R, Kahn R, Klein R, Lachin J, Lebovitz H, Nathan D, Vinicor F: Implications of the United Kingdom Prospective Diabetes Study. Diabetes Care 2003;26(Suppl 1):S28-S32.
5. Guerci B, Floriot M, Bohme P, Durain D, Benichou M, Jellimann S, Drouin P: Clinical performance of CGMS in type 1 diabetic patients treated by continuous subcutaneous insulin infusion using insulin analogs. Diabetes Care 2003;26:582-589.
6. Vincze G, Barner JC, Lopez D: Factors associated with adherence to self-monitoring of blood glucose among persons with diabetes. Diabetes Educ 2004;30:112-125.
7. Mah CA, Soumerai SB, Adams AS, Ross-Degnan D: Racial differences in impact of coverage on diabetes self-monitoring in a health maintenance organization. Med Care 2006;44:392-397.
8. Adams AS, Mah C, Soumerai SB, Zhang F, Barton MB, Ross-Degnan D: Barriers to self-monitoring of blood glucose among adults with diabetes in an HMO: a cross sectional study. BMC Health Serv Res 2003;3:6.
9. Wagner J, Malchoff C, Abbott G: Invasiveness as a barrier to self-monitoring of blood glucose in diabetes. Diabetes Technol Ther 2005;7:612-619.
10. Mastrototaro J: The MiniMed Continuous Glucose Monitoring System (CGMS). J Pediatr Endocrinol Metab 1999;12(Suppl):751-758.
11. Bode B, Gross K, Rikalo N, Schwartz S, Wahl T, Page C, Gross T, Mastrototaro J: Alarms based on real-time sensor glucose values alert patients to hypo- and hyperglycemia: the Guardian continuous monitoring system. Diabetes Technol Ther 2004;6:105-111.
12. Garg SK, Schwartz S, Edelman SV: Improved glucose excursions using an implantable real-time continuous glucose sensor in adults with type 1 diabetes. Diabetes Care 2004;27:734-738.
13. Potts RO, Tamada JA, Tierney MJ: Glucose monitoring by reverse iontophoresis. Diabetes Metab Res Rev 2002;18(Suppl 1):S49-S53.
14. Weinstein RL, Schwartz SL, Brazg RL, Bugler JR, Peyser TA, McGarraugh GV: Accuracy of the 5-day FreeStyle Navigator Continuous Glucose Monitoring System: comparison with frequent laboratory reference measurements. Diabetes Care 2007;30:1125-1130.
15. Clarke WL, Cox D, Gonder-Frederick LA, Carter W, Pohl SL: Evaluating clinical accuracy of systems for self-monitoring of blood glucose. Diabetes Care 1987;10:622-628.
16. Parkes JL, Slatin SL, Pardo S, Ginsberg BH: A new consensus error grid to evaluate the clinical significance of inaccuracies in the measurement of blood glucose. Diabetes Care 2000;23:1143-1148.
17. Clarke WL, Anderson S, Farhy L, Breton M, Gonder-Frederick L, Cox D, Kovatchev B: Evaluating the clinical accuracy of two continuous glucose sensors using continuous glucose-error grid analysis. Diabetes Care 2005;28:2412-2417.
18. Garg S, Jovanovic L: Relationship of fasting and hourly blood glucose levels to HbA1c values: safety, accuracy, and improvements in glucose profiles obtained using a 7-day continuous glucose sensor. Diabetes Care 2006;29:2644-2649.
19. Wilson DM, Beck RW, Tamborlane WV, Dontchev MJ, Kollman C, Chase P, Fox LA, Ruedy KJ, Tsalikian E, Weinzimer SA: The accuracy of the FreeStyle Navigator continuous glucose monitoring system in children with type 1 diabetes. Diabetes Care 2007;30:59-64.
20. Garg SK, Potts RO, Ackerman NR, Fermi SJ, Tamada JA, Chase HP: Correlation of fingerstick blood glucose measurements with GlucoWatch Biographer glucose results in young subjects with type 1 diabetes. Diabetes Care 1999;22:1708-1714.
21. Appendix A: MiniMed Guardian REAL-Time User Guide. Northridge, CA: Medtronic MiniMed, 2007:141-152.
22. Garg S, Zisser H, Schwartz S, Bailey T, Kaplan R, Ellis S, Jovanovic L: Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial. Diabetes Care 2006;29:44-50.
23. Bode B, Bergenstal R, Weinstein R, Bernstein R, Schwartz S, El-Deiry S, Bugler J: Performance of the FreeStyle Navigator Continuous Glucose Monitoring System during home use [abstract 2-LB]. Presented at the American Diabetes Association 66th Scientific Sessions, June 9-13, 2006, Washington, DC. http://scientificsessions.diabetes.org/Abstracts/index.cfm?fuseaction=Locator. SearchAbstracts (accessed July 2, 2008).